FDA Drug Recalls

Recalls / Class III

Class IIID-0381-2022

Product

Kroger, Allergy Relief-D, Fexofenadine HCl 60mg/Antihistamine Pseudoephedrine HCl 120mg/Nasal Decongestant, Extended-Release Tablets USP, 20 tablets per box, NDC 30142-611-14, Distributed by the Kroger Co., Cincinnati, Ohio, 45202, Made in India.

Brand name
Fexofenadine Hcl And Pseudoephedrine Hci
Generic name
Fexofenadine Hcl And Pseudoephedrine Hci
Active ingredients
Fexofenadine Hydrochloride, Pseudoephedrine Hydrochloride
Route
Oral
NDC
30142-611
FDA application
ANDA076667
Affected lot / code info
Lot #s: AC2000968E, Exp. 8/31/2022; AC2103328A; AC2103330I, Exp. 1/31/2023; AC2106452B, Exp. 3/31/2023.

Why it was recalled

Failed Dissolution Specifications

Recalling firm

Firm
Dr. Reddy's Laboratories, Inc.
Manufacturer
The Kroger Co.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
107 College Rd E, N/A, Princeton, New Jersey 08540-6623

Distribution

Quantity
11,064 boxes
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2022-01-04
FDA classified
2022-01-18
Posted by FDA
2022-01-26
Terminated
2023-10-20
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0381-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.